Drug Profile
Research programme: diagnostic imaging - CDG Therapeutics
Alternative Names: p-18Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator University of Illinois at Chicago
- Developer CDG Therapeutics
- Class Bacterial proteins; Imaging agents; Peptide diagnostics
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer(Diagnosis) in USA
- 02 Jun 2011 Preclinical trials in Cancer (diagnosis) in USA (unspecified route)